← FDA Drug Approvals (Drugs@FDA)
TESTOSTERONE CYPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2026-09-03
Drug application
- FDA Application #
ANDA219478- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TESTOSTERONE CYPIONATE
- Generic name
- Testosterone Cypionate
- Active ingredients
- TESTOSTERONE CYPIONATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BPI LABS
- First approval
- 2026-09-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown